Inotiv Completes $51.7M Public Offering

Inotiv, Inc. (Nasdaq: NOTV), a contract research organization specializing in nonclinical and analytical drug discovery and development services, completed an underwritten public offering of $51.7 million of its common shares, including the full exercise by the underwriter of its option to purchase additional shares to cover over-allotments, on April 23, 2021. Colliers Securities LLC acted as Bookrunner and Sole Underwriter. Faegre Drinker represented Colliers Securities in the offering.